Circulating N‐Linked Glycoprotein Side‐Chain Biomarker, Rosuvastatin Therapy, and Incident Cardiovascular Disease: An Analysis From the JUPITER Trial

BACKGROUND: GlycA, a novel protein glycan biomarker of N‐acetyl side chains of acute‐phase proteins, was recently associated with incident cardiovascular disease (CVD) in healthy women. Whether GlycA predicts CVD events in the setting of statin therapy in men and women without CVD but with evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinkuolie, Akintunde O., Glynn, Robert J., Padmanabhan, Latha, Ridker, Paul M, Mora, Samia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015410/
https://www.ncbi.nlm.nih.gov/pubmed/27413042
http://dx.doi.org/10.1161/JAHA.116.003822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015410/
https://www.ncbi.nlm.nih.gov/pubmed/27413042
http://dx.doi.org/10.1161/JAHA.116.003822

Ejemplares similares